Suspended

NIBED pilotRandomized, Controlled, Cross-over, First-in-man Safety and Efficacy Trial of a Novel Non-invasive Bladder Emptying Device: The NIBED Study

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Non-invasive bladder emptying device

Device
Who is being recruted

Urinary Bladder, Underactive+10

+ Urogenital Diseases

+ Urinary Bladder Diseases

Over 18 Years
+21 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: July 2021
See protocol details

Summary

Principal SponsorInsel Gruppe AG, University Hospital Bern
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: July 26, 2021

Actual date on which the first participant was enrolled.

The non-invasive bladder emptying device (NIBED) is a handheld medical device that is applied to the penis during urinating to aid bladder emptying in urinary retention patients with increased residual urine volume. This pilot study primarily seeks to determine the safety of the NIBED. Secondary objectives are to assess the efficacy of the NIBED, which is defined as the ability of the medical device to aid or improve bladder emptying, i.e. leads to less residual urine compared to not using the NIBED. During the intervention, the study participant will urinate with and without the NIBED. Safety variables such as penile pain, penile lesions and hematuria will be recorded. Efficacy will be assessed by measuring voided volume, residual volume, voiding time and urine flow rate.

Official TitleRandomized, Controlled, Cross-over, First-in-man Safety and Efficacy Trial of a Novel Non-invasive Bladder Emptying Device: The NIBED Study
NCT04919798
Principal SponsorInsel Gruppe AG, University Hospital Bern
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

10 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Male

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urinary Bladder, UnderactiveUrogenital DiseasesUrinary Bladder DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsSigns and SymptomsPathological Conditions, Signs and SymptomsUrination DisordersUrologic DiseasesUrinary RetentionUrological ManifestationsFemale Urogenital DiseasesMale Urogenital DiseasesLower Urinary Tract Symptoms

Criteria

4 inclusion criteria required to participate
Informed Consent as documented by signature

Age 18 years or older

Sex: male

Diagnosed with underactive bladder (UAB) (confirmed with urodynamic testing)

17 exclusion criteria prevent from participating
Pain during voiding (NPRS >2)

Acute urinary tract infection

Patients on anti-coagulants (exception Aspirin)

Penile pain (NPRS score >2)

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Urinating with NIBED first, without NIBED second

Group II

Experimental
Urinating without NIBED first, with NIBED second

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Bern University Hospital Inselspital

Bern, SwitzerlandOpen Bern University Hospital Inselspital in Google Maps
SuspendedOne Study Center